Beilstein J. Org. Chem. 2015, 11, 1815–1822.
15.6 Hz, 1H), 5.81 (dt, J = 15.4, 6.6 Hz, 1H), 5.62 (dt, J = 15.4, 6.07 (d, J = 11.5 Hz, 1H), 5.80 (obs. ddd, J = 16.8, 10.6, 5.7 Hz,
6.2 Hz, 1H), 4.63 (d, J = 6.6 Hz, 2H), 2.14 (app. q, J = 7.1 Hz, 1H), 5.80 (obs. d, J = 15.2 Hz, 1H), 5.23–5.11 (obs. m, 1H),
2H), 1.43 (app. sext, J = 7.4 Hz, 2H), 0.92 (t, J = 7.3 Hz, 3H); 5.18 (obs. d, J = 17.2 Hz, 1H), 5.05 (d, J = 10.3 Hz, 1H), 4.53
13C NMR (125 MHz, CDCl3) δ 166.8, 144.7, 140.4, 136.3, (d, J = 11.5 Hz, 1H), 4.48 (d, J = 11.5 Hz, 1H), 4.25 (app. q, J =
136.0, 129.0, 128.8, 127.2, 126.2, 124.0, 121.2, 65.2, 34.3, 22.0, 6.2 Hz, 1H), 3.80 (s, 3H), 3.67 (app. d, J = 4.9 Hz, 2H),
13.6; IR (neat) cm−1: 2958 (m), 2929 (m), 1706 (s), 1625 (s), 2.69–2.54 (complex m, 3H), 2.36 (ddd, J = 13.0, 6.5, 5.5 Hz,
1449 (m), 1236 (s), 1172 (s), 997 (m), 689 (m); HRMS (ESI) 1H), 1.92 (s, 3H), 0.87 (s, 9H), 0.13 (s, 9H), 0.01 (s, 6H);
m/z: [M + H]+ calcd for C17H21O2, 257.1536 found, 257.1529, 13C NMR (500 MHz, CDCl3) δ 166.71, 166.69, 159.2, 146.58,
(Δ = 2.7 ppm).
146.56, 141.70, 141.67, 140.9, 130.1, 129.3, 126.09, 129.07,
118.89, 118.87, 114.2, 113.8, 102.0, 86.92, 86.90, 73.00, 72.99,
(1′R,2′S,5′R,2E,4E,6E)-2′-Isopropyl-5′-methylcyclohex-1′-yl 72.86, 72.82, 70.48, 70.47, 69.45, 69.41, 55.2, 41.7, 25.83,
deca-2,4,6-trienoate (11f). Rf = 0.14 (40:1 pet. ether:Et2O); 25.82, 25.64, 25.62, 22.32, 22.29, 18.1, 0.00, −0.01, −4.54,
1H NMR (500 MHz, CDCl3) δ 7.28 (dd, J = 15.4, 11.2 Hz, 1H), −4.88; IR (neat) cm−1: 2956 (s), 2857 (m), 2180 (w), 1714 (s),
6.53 (dd, J = 14.9, 10.7 Hz, 1H), 6.21 (dd, J = 14.9, 11.2 Hz, 1636 (m), 1513 (m), 1249 (s), 1033 (m), 837 (s), 775 (m), 760
1H), 6.13 (dd, J = 15.1, 10.7 Hz, 1H), 5.92 (dt, J = 14.9, 7.2 Hz, (m); HRMS (ESI) m/z: [M + H]+ calcd for C32H51O5Si2,
1H), 5.83 (d, J = 15.4 Hz, 1H), 4.75 (app. td, J = 10.9, 4.4 Hz, 571.3270; found, 571.3276, (Δ = 1.1 ppm).
1H), 2.12 (app. q, J = 7.3 Hz, 2H), 2.02 (br d, J = 12.2 Hz, 1H),
1.88 (septd, J = 6.8, 2.3 Hz, 1H), 1.71–1.65 (complex m, 2H), (2E,4Z)-1′-(para-Methoxybenzyloxy)pent-4′-yn-2′-yl 7-(tert-
1.50 (partially obs. m, 1H), 1.44 (m, 2H), 1.40 (partially obs. m, butyldimethylsilyloxy)-5-methylnona-2,4,8-trienoate (5c).
1H), 1.07 (app. qd, J = 12.9, 2.9 Hz, 1H), 0.99 (app. q, J = Rf = 0.32 (80% CH2Cl2 in n-hexane); 1H NMR (500 MHz,
11.5 Hz, 1H), 0.91 (t, J = 7.3 Hz, 3H), 0.90 (d, J = 6.1 Hz, 3H), CDCl3) δ 7.58 (dd, J = 14.9, 11.7 Hz, 1H), 7.26 (d, J = 8.6 Hz,
0.89 (d, J = 6.8 Hz, 3H), 0.87 (partially obs. m, 1H), 0.76 (d, 2H), 6.87 (d, J = 8.6 Hz, 2H), 6.07 (d, J = 11.5 Hz, 1H), 5.80
J = 7.1 Hz, 3H); 13C NMR (125 MHz, CDCl3) δ 166.8, 144.6, (obs. ddd, J = 17.1, 10.5, 5.9 Hz, 1H), 5.80 (obs. d, J = 14.9 Hz,
141.0, 140.2, 130.0, 127.8, 120.5, 73.9, 47.2, 41.0, 35.0, 34.3, 1H), 5.23–5.14 (obs. m, 1H), 5.18 (obs. d, J = 16.9 Hz, 1H),
31.4, 26.3, 23.6, 22.2, 22.0, 20.7, 16.4, 13.7; IR (neat) cm−1: 5.05 (d, J = 10.3 Hz, 1H), 4.53 (d, J = 11.5 Hz, 1H), 4.48 (d, J =
2955 (s), 2930 (s), 2869 (s), 1694 (s), 1615 (s), 1456 (m), 1342 11.5 Hz, 1H), 4.25 (app. q, J = 5.6 Hz, 1H), 3.80 (s, 3H),
(m), 1133 (s), 1007 (s); HRMS (ESI) m/z: [M + H]+ calcd for 3.71–3.62 (m, 2H), 2.65 (ddd, J = 16.9, 6.6, 2.7 Hz, 1H), 2.58
C20H33O2, 305.2475; found, 305.2486, (Δ = 3.6 ppm). [α]D22 = (ddd, J = 16.9, 5.4, 2.5 Hz, 1H), 2.61–2.54 (obs. m, 1H), 2.36
−26 (c 0.42, CH2Cl2).
(app. dt, J = 13.1, 4.9 Hz, 1H), 1.97 (m, 1H), 1.92 (s, 3H), 0.86
(s, 9H), 0.01 (s, 3H), 0.00 (s, 3H); 13C NMR (500 MHz,
(2E,4E)-[1′-(para-Methoxybenzyloxy)-5′-trimethylsilyl]pent- CDCl3) δ 166.7, 159.2, 146.81, 146.78, 141.92, 141.89, 140.95,
4′-yn-2′-yl 5-phenylpenta-2,4-dienoate (11h). Rf = 0.28 (80% 140.93, 130.1, 129.31, 129.30, 126.07, 126.05, 118.71, 118.68,
CH2Cl2 in n-hexane); 1H NMR (500 MHz, CDCl3) δ 7.51–7.44 114.2, 113.8, 79.6, 73.0, 72.81, 72.77, 70.33, 70.30, 70.18,
(complex m, 3H), 7.37 (app. t, J = 7.1 Hz, 2H), 7.33 (m, 1H), 70.13, 69.3, 55.2, 41.8, 25.8, 25.66, 25.65, 20.97, 20.95, 18.1,
7.28 (br d, J = 8.8 Hz, 2H), 6.95–6.84 (complex m, 4H), 6.02 −4.54, −4.88; IR (neat) cm−1: 3308 (w), 2930 (m), 2857 (s),
(d, J = 15.4 Hz, 1H), 5.20 (app. dt, J = 10.5, 5.7 Hz, 1H), 4.55 2214 (w), 1712 (s), 1635 (m), 1612 (m), 1514 (s), 1248 (s),
(d, J = 11.5 Hz, 1H), 4.50 (d, J = 11.7 Hz, 1H), 3.80 (s, 3H), 1033 (m), 836 (s), 776 (s); HRMS (ESI) m/z: [M + H]+ calcd
3.72–3.67 (m, 2H), 2.68 (dd, J = 17.1, 7.1 Hz, 1H), 2.63 (dd, for C29H43O5Si, 499.2874; found, 499.2868, (Δ = 1.2 ppm).
J = 16.9, 5.9 Hz, 1H), 0.14 (s, 9H); 13C NMR (125 MHz,
CDCl3) δ 166.2, 159.2, 145.2, 140.7, 136.0, 130.1, 129.3,
Supporting Information
129.1, 128.8, 127.2, 126.2, 121.0, 113.8, 101.9, 87.1, 73.0, 70.7,
69.4, 55.2, 22.3, 0.00; IR (neat) cm−1: 3028 (w), 2957 (m),
Supporting Information File 1
2901 (m), 2178 (m), 1709 (s), 1625 (s), 1512 (m), 1245 (s),
1128 (s), 840 (s), 757 (s); HRMS (ESI) m/z: [M + H]+ calcd for
C27H33O4Si, 449.2143; found, 449.2146, (Δ = 0.67 ppm).
Full experimental methods; spectroscopic data and NMR
spectra of all new compounds.
(2E,4Z)-1′-(para-Methoxybenzyloxy)-5′-(trimethylsilyl-
oxy)pent-4′-yn-2′-yl 7-(tert-butyldimethylsilyloxy)-5-methyl-
nona-2,4,8-trienoate (5b). Rf = 0.30 (80% CH2Cl2 in
n-hexane); 1H NMR (500 MHz, CDCl3) δ 7.57 (dd, J = 14.9,
11.8 Hz, 1H), 7.26 (d, J = 8.3 Hz, 2H), 6.87 (d, J = 8.3 Hz, 2H),
Acknowledgements
The authors gratefully acknowledge financial support from
Genesis Oncology Trust and the Health Research Council of
1820